Ruggero G Fariello Selected Research

methanesulfonyl fluoride

5/2013

A randomized phase I study of methanesulfonyl fluoride, an irreversible cholinesterase inhibitor, for the treatment of Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ruggero G Fariello Research Topics

Disease

3	Parkinson Disease (Parkinson's Disease) 01/2007 - 06/2004
2	Neuralgia (Stump Neuralgia) 06/2014 - 03/2005
1	Painful Neuropathy 06/2014
1	Osteoarthritis 06/2014
1	Hyperalgesia 06/2014
1	Sarcopenia 01/2014
1	Alzheimer Disease (Alzheimer's Disease) 05/2013
1	Epilepsy (Aura) 01/2007
1	Pain (Aches) 03/2005

Drug/Important Bio-Agent (IBA)

1	Pharmaceutical PreparationsIBA 06/2014
1	Nootropic Agents (Nootropics)IBA 06/2014
1	2-pyrrolidoneIBA 06/2014
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2014
1	dimiracetamIBA 06/2014
1	muskIBA 01/2014
1	neurotrypsinIBA 01/2014
1	Biological ProductsIBA 01/2014
1	AgrinIBA 01/2014
1	methanesulfonyl fluorideIBA 05/2013
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 05/2013
1	safinamideIBA 01/2007
1	Anticonvulsants (Antiepileptic Drugs)IBA 03/2005
1	Carbamazepine (Tegretol)FDA LinkGeneric 03/2005
1	Tetrodotoxin (Tetradotoxin)IBA 03/2005
1	Dopamine (Intropin)FDA LinkGeneric 07/2004
1	Monoamine Oxidase (MAO)IBA 07/2004
1	MetalsIBA 06/2004
1	NoxaeIBA 06/2004

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 06/2014